403 related articles for article (PubMed ID: 15530697)
1. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
[TBL] [Abstract][Full Text] [Related]
2. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Knowlton DR; McNeal MM; Ward RL
Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
[TBL] [Abstract][Full Text] [Related]
3. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
4. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
[TBL] [Abstract][Full Text] [Related]
5. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.
Liu X; Yang T; Sun QM; Sun MS
Acta Virol; 2005; 49(1):17-22. PubMed ID: 15929394
[TBL] [Abstract][Full Text] [Related]
6. Mucosal and systemic antibody responses and protection induced by a prime/boost rotavirus-DNA vaccine in a gnotobiotic pig model.
Yuan L; Azevedo MS; Gonzalez AM; Jeong KI; Van Nguyen T; Lewis P; Iosef C; Herrmann JE; Saif LJ
Vaccine; 2005 Jun; 23(30):3925-36. PubMed ID: 15917114
[TBL] [Abstract][Full Text] [Related]
7. VP6: A candidate rotavirus vaccine.
Ward RL; McNeal MM
J Infect Dis; 2010 Sep; 202 Suppl():S101-7. PubMed ID: 20684688
[TBL] [Abstract][Full Text] [Related]
8. Development of a Bacillus subtilis-based rotavirus vaccine.
Lee S; Belitsky BR; Brinker JP; Kerstein KO; Brown DW; Clements JD; Keusch GT; Tzipori S; Sonenshein AL; Herrmann JE
Clin Vaccine Immunol; 2010 Nov; 17(11):1647-55. PubMed ID: 20810679
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
10. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice.
Choi AH; Basu M; McNeal MM; Bean JA; Clements JD; Ward RL
Protein Expr Purif; 2004 Dec; 38(2):205-16. PubMed ID: 15555936
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice.
Zhou B; Zhang Y; Wang X; Dong J; Wang B; Han C; Yu J; Li D
Vaccine; 2010 Aug; 28(37):6021-7. PubMed ID: 20637305
[TBL] [Abstract][Full Text] [Related]
12. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice.
McNeal MM; Basu M; Bean JA; Clements JD; Choi AH; Ward RL
Virology; 2007 Jul; 363(2):410-8. PubMed ID: 17337285
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.
Dennehy M; Bourn W; Steele D; Williamson AL
Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069
[TBL] [Abstract][Full Text] [Related]
14. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
[TBL] [Abstract][Full Text] [Related]
15. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
[TBL] [Abstract][Full Text] [Related]
16. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice.
Shuttleworth G; Eckery DC; Awram P
Arch Virol; 2005 Feb; 150(2):341-9. PubMed ID: 15578236
[TBL] [Abstract][Full Text] [Related]
17. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.
Choi AH; McNeal MM; Basu M; Flint JA; Stone SC; Clements JD; Bean JA; Poe SA; VanCott JL; Ward RL
Vaccine; 2002 Sep; 20(27-28):3310-21. PubMed ID: 12213401
[TBL] [Abstract][Full Text] [Related]
18. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination.
McNeal MM; Broome RL; Ward RL
Virology; 1994 Nov; 204(2):642-50. PubMed ID: 7941332
[TBL] [Abstract][Full Text] [Related]
19. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.
McNeal MM; Stone SC; Basu M; Bean JA; Clements JD; Hendrickson BA; Choi AH; Ward RL
Virology; 2006 Mar; 346(2):338-47. PubMed ID: 16375942
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of VP6 immunogenicity and protective efficacy against rotavirus by VP2 in a genetic immunization.
Lopez-Guerrero DV; Arias N; Gutierrez-Xicotencatl L; Chihu-Amparan L; González A; Pedroza-Saavedra A; Rosas-Salgado G; Villegas-Garcia JC; Badillo-Godinez O; Fernandez G; Lopez S; Esquivel-Guadarrama F
Vaccine; 2018 May; 36(22):3072-3078. PubMed ID: 28465094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
